BACKGROUND: few studies describe patterns of human immunodeficiency virus (HIV) co-infections in African hospitals in the antiretroviral therapy (ART) era. METHODS: we enrolled consecutive admitted patients aged ≥ 13 years with oral temperature of ≥ 38.0°C during 1 year in Moshi, Tanzania. A standardized clinical history and physical examination was done and hospital outcome recorded. HIV antibody testing, aerobic and mycobacterial blood cultures, and malaria film were performed. HIV-infected patients also received serum cryptococcal antigen testing and CD4(+) T lymphocyte count (CD4 cell count). RESULTS: of 403 patients enrolled, the median age was 38 years (range, 14-96 years), 217 (53.8%) were female, and 157 (39.0%) were HIV-infected. Of HIV-infected patients, the median CD4 cell count was 98 cells/μL (range, 1-1,105 cells/ μL), 20 (12.7%) were receiving ART, and 29 (18.5%) were receiving trimethoprim-sulfamethoxazole prophylaxis. There were 112 (27.7%) patients who had evidence of invasive disease, including 26 (23.2%) with Salmonella serotype Typhi infection, 24 (21.4%) with Streptococcus pneumoniae infection, 17 (15.2%) with Cryptococcus neoformans infection, 12 (10.7%) with Mycobacterium tuberculosis complex infection, 8 (7.1%) with Plasmodium falciparum infection, and 7 (6.3%) with Escherichia coli infection. HIV infection was associated with M. tuberculosis and C. neoformans bloodstream infection but not with E. coli, S. pneumoniae, or P. falciparum infection. HIV infection appeared to be protective against Salmonella. Typhi bloodstream infection (odds ratio, .12; P = .001). CONCLUSIONS: while Salmonella Typhi and S. pneumoniae were the most common causes of invasive infection overall, M. tuberculosis and C. neoformans were the leading causes of bloodstream infection among HIV-infected inpatients in Tanzania in the ART era. We demonstrate a protective effect of HIV against Salmonella. Typhi bloodstream infection in this setting. HIV co-infections continue to account for a large proportion of febrile admissions in Tanzania.
BACKGROUND: few studies describe patterns of human immunodeficiency virus (HIV) co-infections in African hospitals in the antiretroviral therapy (ART) era. METHODS: we enrolled consecutive admitted patients aged ≥ 13 years with oral temperature of ≥ 38.0°C during 1 year in Moshi, Tanzania. A standardized clinical history and physical examination was done and hospital outcome recorded. HIV antibody testing, aerobic and mycobacterial blood cultures, and malaria film were performed. HIV-infected patients also received serum cryptococcal antigen testing and CD4(+) T lymphocyte count (CD4 cell count). RESULTS: of 403 patients enrolled, the median age was 38 years (range, 14-96 years), 217 (53.8%) were female, and 157 (39.0%) were HIV-infected. Of HIV-infected patients, the median CD4 cell count was 98 cells/μL (range, 1-1,105 cells/ μL), 20 (12.7%) were receiving ART, and 29 (18.5%) were receiving trimethoprim-sulfamethoxazole prophylaxis. There were 112 (27.7%) patients who had evidence of invasive disease, including 26 (23.2%) with Salmonella serotype Typhi infection, 24 (21.4%) with Streptococcus pneumoniae infection, 17 (15.2%) with Cryptococcus neoformans infection, 12 (10.7%) with Mycobacterium tuberculosis complex infection, 8 (7.1%) with Plasmodium falciparum infection, and 7 (6.3%) with Escherichia coli infection. HIV infection was associated with M. tuberculosis and C. neoformans bloodstream infection but not with E. coli, S. pneumoniae, or P. falciparum infection. HIV infection appeared to be protective against Salmonella. Typhi bloodstream infection (odds ratio, .12; P = .001). CONCLUSIONS: while Salmonella Typhi and S. pneumoniae were the most common causes of invasive infection overall, M. tuberculosis and C. neoformans were the leading causes of bloodstream infection among HIV-infected inpatients in Tanzania in the ART era. We demonstrate a protective effect of HIV against Salmonella. Typhi bloodstream infection in this setting. HIV co-infections continue to account for a large proportion of febrile admissions in Tanzania.
Authors: Lisa M Bebell; Christopher D Pilcher; Grant Dorsey; Diane Havlir; Moses R Kamya; Michael P Busch; Joan Dunn Williams; Charles T Nugent; Christopher Bentsen; Philip J Rosenthal; Edwin D Charlebois Journal: AIDS Date: 2010-07-31 Impact factor: 4.177
Authors: Grant Mackenzie; Serign J Ceesay; Philip C Hill; Michael Walther; Kalifa A Bojang; Judith Satoguina; Godwin Enwere; Umberto D'Alessandro; Debasish Saha; Usman N A Ikumapayi; Tim O'Dempsey; David C W Mabey; Tumani Corrah; David J Conway; Richard A Adegbola; Brian M Greenwood Journal: PLoS One Date: 2010-05-11 Impact factor: 3.240
Authors: Meghan K Mayhood; Isaac A Afwamba; Christopher O Odhiambo; Epimack Ndanu; Nathan M Thielman; Anne B Morrissey; John F Shao; Brian Wells Pence; John A Crump Journal: J Clin Microbiol Date: 2008-10-15 Impact factor: 5.948
Authors: Katherine L O'Brien; Lara J Wolfson; James P Watt; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Kim Mulholland; Orin S Levine; Thomas Cherian Journal: Lancet Date: 2009-09-12 Impact factor: 79.321
Authors: Philip C Hill; Charles O Onyeama; Usman N A Ikumapayi; Ousman Secka; Samuel Ameyaw; Naomi Simmonds; Simon A Donkor; Stephen R Howie; Mary Tapgun; Tumani Corrah; Richard A Adegbola Journal: BMC Infect Dis Date: 2007-01-26 Impact factor: 3.090
Authors: Simon I Hay; Carlos A Guerra; Peter W Gething; Anand P Patil; Andrew J Tatem; Abdisalan M Noor; Caroline W Kabaria; Bui H Manh; Iqbal R F Elyazar; Simon Brooker; David L Smith; Rana A Moyeed; Robert W Snow Journal: PLoS Med Date: 2009-03-24 Impact factor: 11.069
Authors: John A Crump; Marion J Tuohy; Anne B Morrissey; Habib O Ramadhani; Boniface N Njau; Venance P Maro; L Barth Reller; Gary W Procop Journal: J Clin Microbiol Date: 2011-10-26 Impact factor: 5.948
Authors: Malavika Prabhu; William L Nicholson; Aubree J Roche; Gilbert J Kersh; Kelly A Fitzpatrick; Lindsay D Oliver; Robert F Massung; Anne B Morrissey; John A Bartlett; Jecinta J Onyango; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; John A Crump Journal: Clin Infect Dis Date: 2011-08 Impact factor: 9.079
Authors: Paula E Brentlinger; Wilson P Silva; Sten H Vermund; Emilio Valverde; Manuel Buene; Troy D Moon Journal: AIDS Res Hum Retroviruses Date: 2015-08-19 Impact factor: 2.205
Authors: Holly M Biggs; Duy M Bui; Renee L Galloway; Robyn A Stoddard; Sean V Shadomy; Anne B Morrissey; John A Bartlett; Jecinta J Onyango; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; John A Crump Journal: Am J Trop Med Hyg Date: 2011-08 Impact factor: 2.345
Authors: S P Fiorillo; H C Diefenthal; P C Goodman; H O Ramadhani; B N Njau; A B Morrissey; V P Maro; W Saganda; G D Kinabo; M S Mwako; J A Bartlett; J A Crump Journal: Clin Radiol Date: 2013-06-26 Impact factor: 2.350
Authors: Sarah M Lofgren; Emily J Kirsch; Venance P Maro; Anne B Morrissey; Levina J Msuya; Grace D Kinabo; Wilbrod Saganda; Helmut C Diefenthal; Habib O Ramadhani; L Joseph Wheat; John A Crump Journal: Trans R Soc Trop Med Hyg Date: 2012-06-26 Impact factor: 2.184
Authors: Andrew J Bouley; Holly M Biggs; Robyn A Stoddard; Anne B Morrissey; John A Bartlett; Isaac A Afwamba; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; Sarah Cleaveland; John A Crump Journal: Am J Trop Med Hyg Date: 2012-10-22 Impact factor: 2.345